We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Declines to Disqualify Minneapolis Investigators and IRB From Running Trials
FDA Declines to Disqualify Minneapolis Investigators and IRB From Running Trials
The FDA has turned down a citizen petition seeking that the investigators and the institutional review board (IRB) at Minneapolis, Minn.-based Hennepin County Medical Center (HCMC) be barred from conducting clinical trials.